Description

Description

Orinase Met (1/500mg) is a dual-action tablet that combines two well-established medicines, Glimepiride and Metformin, into a single dose for the management of type 2 diabetes mellitus. Each pack contains 30 tablets intended for oral use. This combination works through two complementary mechanisms: Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, while Metformin helps reduce the amount of sugar produced by the liver and improves the body’s sensitivity to insulin. Together, this dual approach can offer more comprehensive blood sugar control than either medicine used on its own. Manufactured by CCL Pharmaceuticals, Orinase Met 1/500mg is generally prescribed for patients whose diabetes has not been adequately managed on Metformin alone, or for those who may benefit from starting combination therapy earlier in their treatment journey, always under the guidance of a physician.

Ingredients

Each Orinase Met (1/500mg) tablet contains two active pharmaceutical ingredients: Glimepiride at a strength of 1mg, and Metformin Hydrochloride at a strength of 500mg. Glimepiride belongs to the sulfonylurea class and works by stimulating insulin release from the pancreas, while Metformin belongs to the biguanide class and works primarily by reducing hepatic glucose production and improving insulin sensitivity in body tissues. The tablet also contains standard pharmaceutical-grade excipients, including fillers, binding agents, and disintegrants, along with a coating that supports ease of swallowing. The complete excipient list can be reviewed on the package insert or confirmed with a pharmacist, particularly for patients with known sensitivities to specific components.

Dosage Form

Orinase Met (1/500mg) is supplied as a film-coated oral tablet that combines both active ingredients into a single dosage unit. Each pack contains 30 tablets, offering a convenient one-month supply for patients on a once or twice daily regimen, depending on their doctor’s instructions. As a fixed-dose combination, it removes the need to take two separate tablets, helping simplify the daily treatment routine for patients managing diabetes.

Uses

Orinase Met (1/500mg) is used to help control blood sugar levels in adults with type 2 diabetes mellitus, particularly those who require the combined benefits of increased insulin release and reduced glucose production. It is commonly prescribed for patients who have not achieved adequate blood sugar control using Metformin alone, or for those who need a more comprehensive approach to glycemic management from an earlier stage of treatment. By addressing blood sugar regulation from two different angles, this combination can support more effective long-term control, helping to reduce the risk of diabetes-related complications affecting the heart, kidneys, eyes, and nerves. As with its individual components, Orinase Met is not intended for use in type 1 diabetes or diabetic ketoacidosis.

How to Use

Orinase Met (1/500mg) should be taken exactly as prescribed by a doctor, who will determine the appropriate dosing schedule based on the patient’s blood sugar levels, kidney function, and overall health. It is typically taken with meals, often once or twice daily, to help reduce the risk of gastrointestinal side effects associated with Metformin and to support more predictable absorption. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed unless specifically advised otherwise. Meals should not be skipped after taking this medicine, as doing so can increase the risk of low blood sugar. Any changes to the dose should only be made under medical supervision, and regular monitoring of blood sugar levels, as well as periodic kidney function tests, is generally recommended throughout treatment.

Side Effects

As a combination medicine, Orinase Met (1/500mg) may cause a range of side effects, some related to each individual component. Commonly reported effects include gastrointestinal symptoms such as nausea, diarrhea, stomach upset, or a metallic taste in the mouth, which are often associated with the Metformin component and may lessen over time. Hypoglycemia, or low blood sugar, is a notable concern linked to the Glimepiride component, with symptoms including sweating, shakiness, dizziness, confusion, or sudden hunger. Some patients may also experience headache or mild fatigue. In rare cases, Metformin has been associated with a serious condition called lactic acidosis, particularly in patients with kidney or liver impairment, which requires immediate medical attention if symptoms such as unusual muscle pain, difficulty breathing, or severe weakness occur. Any persistent or severe side effects should be reported to a doctor promptly.

Pregnancy & Breastfeeding

Orinase Met (1/500mg) is generally not recommended for use during pregnancy, as blood sugar management in pregnant women with diabetes typically requires more precise, closely monitored control, often achieved through insulin therapy rather than oral combination medications. Women who are pregnant, planning to conceive, or who suspect they may be pregnant should inform their doctor promptly, as an alternative treatment approach is often considered more suitable in these situations. This medicine is also generally not advised during breastfeeding, as there is limited clarity on how the combined active ingredients may transfer into breast milk or affect a nursing infant. A healthcare provider should always be consulted before continuing or adjusting diabetes treatment during pregnancy or breastfeeding.

Storage Instructions

Orinase Met (1/500mg) tablets should be stored in a cool, dry place, away from direct sunlight and excessive humidity, ideally at normal room temperature. The tablets should remain in their original blister packaging until they are ready to be used, helping to preserve their stability and effectiveness. As with all medications, this product should be stored safely out of the reach and sight of children and pets. Tablets that have passed their expiry date should not be used, and any unused or expired medicine should be disposed of responsibly rather than placed in regular household waste.

FAQs

Q: Why would a doctor prescribe a combination tablet instead of Metformin alone?
A: This combination is often prescribed when Metformin alone has not achieved adequate blood sugar control, allowing the added benefit of increased insulin release from the Glimepiride component.

Q: Can Orinase Met cause low blood sugar?
A: Yes, due to the Glimepiride component, hypoglycemia is possible, particularly if meals are skipped or the dose is not taken as directed. Symptoms should be treated promptly with a fast-acting source of sugar.

Q: Should this medicine be taken with food?
A: Yes, it is generally recommended to take Orinase Met with meals to help reduce the risk of stomach-related side effects and to support more predictable absorption.

Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, unless it is close to the time for your next dose, in which case skip it. Do not double the dose to make up for a missed one.

Q: Will I need regular check-ups while on this medicine?
A: Yes, your doctor will likely recommend periodic blood sugar monitoring and kidney function tests to ensure the medicine remains safe and effective for your treatment.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.